<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>17</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>04</Month>
        <Day>05</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Revealing COVID-19 breakthrough infection rates among vaccinated individuals at a tertiary care centre in South India</title>
    <FirstPage>194</FirstPage>
    <LastPage>203</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Vanathy</FirstName>
        <LastName>Kandhasamy</LastName>
        <affiliation locale="en_US">Department of Microbiology, Mahatma Gandhi Medical College &amp; Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, Puducherry, India</affiliation>
      </Author>
      <Author>
        <FirstName>Ramya</FirstName>
        <LastName>Priyadarshini</LastName>
        <affiliation locale="en_US">Department of Microbiology, Mahatma Gandhi Medical College &amp; Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, Puducherry, India</affiliation>
      </Author>
      <Author>
        <FirstName>Namrata</FirstName>
        <LastName>Bhosale</LastName>
        <affiliation locale="en_US">Department of Microbiology, Vinayaka Mission's Medical College and Hospital, Vinayaka Mission&#x2019;s Research Foundation (Deemed to be University), Karaikal, Puducherry, India</affiliation>
      </Author>
      <Author>
        <FirstName>Raji</FirstName>
        <LastName>Pillai</LastName>
        <affiliation locale="en_US">Department of Microbiology, Mahatma Gandhi Medical College &amp; Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, Puducherry, India</affiliation>
      </Author>
      <Author>
        <FirstName>Malarvizhi</FirstName>
        <LastName>Ramalingam</LastName>
        <affiliation locale="en_US">Department of Microbiology, Mahatma Gandhi Medical College &amp; Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, Puducherry, India</affiliation>
      </Author>
      <Author>
        <FirstName>Agiesh</FirstName>
        <LastName>Balakrishna Pillai</LastName>
        <affiliation locale="en_US">Department of Virology, Scientist F, Advanced Institute of Virology, Trivandrum, Kerala, India</affiliation>
      </Author>
      <Author>
        <FirstName>Ezhumalai</FirstName>
        <LastName>Govindasamy</LastName>
        <affiliation locale="en_US">Department of Deanery Research, Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, Puducherry, India</affiliation>
      </Author>
      <Author>
        <FirstName>Joshy</FirstName>
        <LastName>Maducolil Easow</LastName>
        <affiliation locale="en_US">Department of Microbiology, Mahatma Gandhi Medical College &amp; Research Institute (MGMCRI), Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, Puducherry, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>03</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: The COVID-19 pandemic was mitigated by the rapid development and deployment of vaccines. While vaccines reduce infection severity, breakthrough infections (BTIs) still occur. The CDC defines BTI as a positive SARS-CoV-2 test &#x2265;14 days post-vaccination. This study investigates the occurrence of COVID-19 BTIs at a tertiary care hospital in Puducherry, South India.
Materials and Methods: This retrospective study analysed hospital tested qRT-PCR data of individuals from the ICMR portal (March 2021&#x2013;March 2022). Demographic and vaccination details were extracted.
Results: Among 8001 tested individuals, 1452 were vaccinated. The BTI rate decreased from 16.6% to 1.2% after the first dose and from 58% to 40% after the second one. Odds ratio indicated a 74% reduction in infection risk for vaccinated individuals compared to unvaccinated. Males had higher infection rates than females, regardless of vaccination status.
Conclusion: Our study demonstrates a higher BTI rate after one vaccine dose compared to two doses. The BTI rate also increased four months post-vaccination, even with two doses, potentially due to waning immunity and the emergence of new variants. Therefore, continued adherence to preventive measures in conjunction with vaccination is crucial for minimizing COVID-19 transmission.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/5200</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/5200/1757</pdf_url>
  </Article>
</Articles>
